Company profile

Greenlight biosciences

GreenLight Biosciences, founded in 2008, joined the Unicorn Club in June 2020 after raising a $102 million Series D led by Morningside. Headquartered in Lexington, Massachusetts, United States, the biotech unicorn has raised $225 million across six funding rounds. The company develops RNA-based products for vaccines, antibody therapies, pandemic preparedness, crop protection, and pollinator health. Investors include Morningside, Cormorant Asset Management, and Tao Capital Partners. Funding supports platform expansion, commercial scaling, and RNA-based innovation across human, animal, and agricultural health sectors.

Back to profiles

Quick facts

Total funding: $102 million
Founded: 2008

Notable investors

Morningside
Cormorant Asset Management
Tao Capital Partners

Reach buyers like Greenlight biosciences on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Greenlight biosciences
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Greenlight biosciences.

The 14-day trial ships every feature, no card required.

Start free →